WHO ICTRP trial
Docetaxel,Cisplatin versus Carboplatin,weekly Paclitaxel for patients with…
JPRN-UMIN000001132 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000001132 |
|---|---|
| Public title | Docetaxel,Cisplatin versus Carboplatin,weekly Paclitaxel for patients with advanced non-small cell lung cancer : a prospective randomized phase II study of the Niigata Lung Cancer Treatment Group |
| Scientific title | Docetaxel,Cisplatin versus Carboplatin,weekly Paclitaxel for patients with advanced non-small cell lung cancer : a prospective randomized phase II study of the Niigata Lung Cancer Treatment Group - Docetaxel,Cisplatin versus Carboplatin,weekly Paclitaxel for patients with advanced non-small cell… |
| Primary sponsor | Niigata Lung Cancer Treatment Group |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Non-small cell lung cancer |
| Interventions | Treatment group A: DOC 45mg/m2 day1,15 CDDP 40mg/m2 day1,15 Treatment group B: PTX 70mg/m2 day1,8,15 CBDCA AUC = 6 day1 |
| Registration date | Apr 28, 2008 |
| Target size | 80 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: